ID

24552

Beschrijving

Study part: Study Conclusion. A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients with Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Clinicaltrials.gov Identifier: NCT00355641. Phase: phase 3. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP, Zygara; Zygara, ZIPEREVE, ZEPREVE, Requip Depot, REQUIP, REPREVE, Modutab, ADARTREL. Study Indication : Restless Legs Syndrome. Study ID: 101468/206. Clinical Study ID: 101468/206.

Trefwoorden

Versies (1)
  1. 05-08-17 05-08-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

5 augustus 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Study Conclusion (CONC) Ropinirole Restless Legs Syndrom NCT00355641

Engels

Study Conclusion

1 Formulieren  
  1. StudyEvent: ODM
    1. Study Conclusion
STUDY CONCLUSION
Beschrijving

STUDY CONCLUSION

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
1. Date of subject completion or date of subject withdrawal
Beschrijving

date subject withdrawal

Datatype

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0422727
2. Was the subject withdrawn from the study?
Beschrijving

subject withdrawal

Datatype

boolean

Alias
UMLS CUI [1]
C0422727
If Yes, select primary reason for withdrawal
Beschrijving

reason

Datatype

text

Alias
UMLS CUI [1]
C0392360
Other, specify
Beschrijving

Other

Datatype

text

Alias
UMLS CUI [1]
C0205394
LOG STATUS
Beschrijving

LOG STATUS

Alias
UMLS CUI-1
C1708728
UMLS CUI-2
C0449438
3. Did the subject experience any non-serious adverse events during the study?
Beschrijving

non-serious adverse events

Datatype

boolean

Alias
UMLS CUI [1]
C1518404
4. Did the subject experience any serious adverse events during the study?
Beschrijving

serious adverse events

Datatype

boolean

Alias
UMLS CUI [1]
C1519255
5. Were any concomitant medications taken by the subject prior to screening and/or during the study?
Beschrijving

concomitant medications

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
6. Case book ready for signature
Beschrijving

signature

Datatype

boolean

Alias
UMLS CUI [1]
C1519316
7. Q1
Beschrijving

Q1

Datatype

boolean

8. Q2
Beschrijving

Q2

Datatype

text

Terug naar het begin van de pagina

Similar models

Study Conclusion

1 Formulieren
  1. StudyEvent: ODM
    1. Study Conclusion
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
STUDY CONCLUSION
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
date subject withdrawal
Item
1. Date of subject completion or date of subject withdrawal
date
C0011008 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
subject withdrawal
Item
2. Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item
If Yes, select primary reason for withdrawal
text
C0392360 (UMLS CUI [1])
reason
Code List
If Yes, select primary reason for withdrawal
CL Item
Adverse Event (Adverse Event)
C0877248 (UMLS CUI-1)
(Comment:en)
CL Item
Lost to follow-up (Lost to follow-up)
C1302313 (UMLS CUI-1)
(Comment:en)
CL Item
Protocol violation (Protocol violation)
C1709750 (UMLS CUI-1)
(Comment:en)
CL Item
Subject decided to withdraw from the study (Subject decided to withdraw from the study)
C2348571 (UMLS CUI-1)
(Comment:en)
CL Item
Insufficient therapeutic effect (Insufficient therapeutic effect)
C1546939 (UMLS CUI-1)
(Comment:en)
CL Item
Other (Other)
C0205394 (UMLS CUI-1)
(Comment:en)
Other
Item
Other, specify
text
C0205394 (UMLS CUI [1])
Item Group
LOG STATUS
C1708728 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
non-serious adverse events
Item
3. Did the subject experience any non-serious adverse events during the study?
boolean
C1518404 (UMLS CUI [1])
serious adverse events
Item
4. Did the subject experience any serious adverse events during the study?
boolean
C1519255 (UMLS CUI [1])
concomitant medications
Item
5. Were any concomitant medications taken by the subject prior to screening and/or during the study?
boolean
C2347852 (UMLS CUI [1])
signature
Item
6. Case book ready for signature
boolean
C1519316 (UMLS CUI [1])
Q1
Item
7. Q1
boolean
Item
8. Q2
text
Q2
Code List
8. Q2
CL Item
PF_SC_LOST (PF_SC_LOST)
CL Item
PF_SC_DEATH (PF_SC_DEATH)
CL Item
PF_SC_SPONSORDECISION (PF_SC_SPONSORDECISION)
CL Item
PF_SC_PHYSICIANDECISION (PF_SC_PHYSICIANDECISION)
CL Item
PF_SC_PATIENTDECISION (PF_SC_PATIENTDECISION)
CL Item
PF_SC_AE (PF_SC_AE)
CL Item
PF_SC_ALE (PF_SC_ALE)
CL Item
PF_SC_CRITERIA (PF_SC_CRITERIA)
CL Item
PF_SC_OTHER (PF_SC_OTHER)
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial